Drawing for STANDING TOGETHER WITH PATIENTS

USPTO serial 79425959

STANDING TOGETHER WITH PATIENTS

Reviewed by CopyMark Law Group

Reg. 8248647Status 700Registered
Filing date
Status date
Registration date
May 12, 2026
Examiner
OSBORNE, AUDRIANA R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STANDING TOGETHER WITH PATIENTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powders, pills, capsules, granules, jellies or liquids; dietary supplements for human beings; dietary fiber to aid digestion; lyophilised food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babiesACTIVE
044Provision of medical and pharmaceutical information via the Internet; provision of medical information relating to benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; Medical and pharmaceutical consultation, namely, advisory services in the field of pharmaceutical products; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; Consultancy in the field of the medical diagnosis of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications via the Internet; online medical counseling services; Remote monitoring of medical data for medical diagnosis and treatment, namely, remote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; providing medical information; physical examination services; Providing medical information, namely, information about pharmaceuticals, medical services and health; Medical consultancy relating to medical services, pharmaceuticals, health and dispensing of medications; Medical consultancy, advisory and provision of information relating to dieting, nutritional intake and health care; Medical consultancy, advisory and provision of information relating to health care; managed health care services; Providing health information, namely, provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; Medical nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; nursing care; rental of medical apparatus and instrumentsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 12, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 19, 2026GPNXNOTIFICATION PROCESSED BY IB
Mar 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 11, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 10, 2025RFNTREFUSAL PROCESSED BY IB
Sep 24, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2025RFRRREFUSAL PROCESSED BY MPU
Aug 13, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2025DOCKASSIGNED TO EXAMINER
Jun 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jun 24, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 19, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance